Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PoliNat is a Spanish biotechnology company specializing in the research, development, and manufacture of natural plant extracts for the health and wellness industries. Founded in 1999 and headquartered in the Canary Islands, the company focuses on bioactive compounds, particularly polyphenols, derived from Mediterranean fruits and vegetables. Their product portfolio includes standardized extracts from pomegranates, olives, and grapes, which are used in nutraceuticals, functional foods, and pharmaceutical applications. The company utilizes advanced extraction and purification technologies to ensure high concentrations of active molecules like anthocyanins and hydroxytyrosol. In 2006, PoliNat was acquired by Frutarom, which was later integrated into International Flavors & Fragrances (IFF), expanding its global reach. Today, it operates as part of IFF's Health & Biosciences division, continuing to provide science-backed botanical solutions for metabolic and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PoliNat.